Risk of SARS-CoV-2 Infection and Hospitalisation in Immunocompromised Children: A Population-Based Cohort Study in

Costanza Di Chiara1,2,3, Riccardo Boracchini4, Nhung T H Trinh5

  • 1Department for Women's and Children's Health, University of Padua, Padua, Italy.

Insights

Immunocompromised children (IC) did not face higher SARS-CoV-2 infection risks. However, IC children showed increased hospitalisation rates, suggesting precautionary management rather than greater disease severity.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Immunocompromised children (IC) were presumed at higher risk for SARS-CoV-2 infection and severe COVID-19.
  • Limited population-based evidence exists regarding COVID-19 outcomes in pediatric populations with compromised immune systems.

Purpose of the Study:

  • To assess SARS-CoV-2 infection risk, COVID-19 hospitalization rates, and severe outcomes in immunocompromised children (IC) compared to children with other high-risk conditions (non-IC) and reference children (RC).

Main Methods:

  • Retrospective population-based cohort study utilizing electronic health registries from Italy and Norway (February 2020-February 2022).
  • Included children aged 1-14 years, classified into IC, non-IC, and RC groups.
  • Adjusted models were used to estimate infection and hospitalization risks.

Main Results:

  • Infection rates were similar across all groups in both countries.
  • Hospitalizations were rare overall. In Norway, adjusted hazard ratios for hospitalization were 5.29 (IC vs. RC) and 2.30 (IC vs. non-IC).
  • Severe COVID-19 cases were low (zero in Italy, five in Norway).

Conclusions:

  • Immunocompromised children (IC) did not exhibit an increased risk of SARS-CoV-2 infection.
  • IC children experienced higher hospitalization rates, potentially due to precautionary clinical management rather than increased disease severity.
  • The study highlights the need for careful monitoring and management strategies for immunocompromised children during viral outbreaks.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...